CX3CL1-CX3CR1 interaction prevents carbon tetrachloride-induced liver inflammation and fibrosis in mice

Authors

  • Tomonori Aoyama,

    1. Division of Gastroenterology, Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA
    Search for more papers by this author
  • Sayaka Inokuchi,

    1. Division of Gastroenterology, Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA
    Search for more papers by this author
  • David A. Brenner,

    1. Division of Gastroenterology, Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA
    Search for more papers by this author
  • Ekihiro Seki

    Corresponding author
    1. Division of Gastroenterology, Department of Medicine, University of California San Diego School of Medicine, La Jolla, CA
    • Division of Gastroenterology, Department of Medicine, University of California San Diego School of Medicine, 9500 Gilman Drive, MC 0702, Leichtag Biomedical Research Building, Room 332MM, La Jolla, CA 92093-0702
    Search for more papers by this author
    • fax: 858-822-5370


  • Potential conflict of interest: Nothing to report.

Abstract

Chronic liver disease is associated with hepatocyte injury, inflammation, and fibrosis. Chemokines and chemokine receptors are key factors for the migration of inflammatory cells such as macrophages and noninflammatory cells such as hepatic stellate cells (HSCs). The expression of CX3CR1 and its ligand, CX3CL1, is up-regulated in chronic liver diseases such as chronic hepatitis C. However, the precise role of CX3CR1 in the liver is still unclear. Here we investigated the role of the CX3CL1-CX3CR1 interaction in a carbon tetrachloride (CCl4)–induced liver inflammation and fibrosis model. CX3CR1 was dominantly expressed in Kupffer cells in the liver. In contrast, the main source of CX3CL1 was HSCs. Mice deficient in CX3CR1 showed significant increases in inflammatory cell recruitment and cytokine production [including tumor necrosis factor α (TNF-α); monocyte chemoattractant protein 1; macrophage inflammatory protein 1β; and regulated upon activation, normal T cell expressed, and secreted (RANTES)] after CCl4 treatment versus wild-type (WT) mice. This suggested that CX3CR1 signaling prevented liver inflammation. Kupffer cells in CX3CR1-deficient mice after CCl4 treatment showed increased expression of TNF-α and transforming growth factor β and reduced expression of the anti-inflammatory markers interleukin-10 (IL-10) and arginase-1. Coculture experiments showed that HSCs experienced significantly greater activation by Kupffer cells from CCl4-treated CX3CR1-deficient mice versus WT mice. Indeed, augmented fibrosis was observed in CX3CR1-deficient mice versus WT mice after CCl4 treatment. Finally, CX3CL1 treatment induced the expression of IL-10 and arginase-1 in WT cultured Kupffer cells through CX3CR1, which in turn suppressed HSC activation. Conclusion: The CX3CL1-CX3CR1 interaction inhibits inflammatory properties in Kupffer cells/macrophages and results in decreased liver inflammation and fibrosis. (Hepatology 2010)

Ancillary